AVDL
Avadel Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
AVDL Filings
Filing Date
Form Description
Form Type
2026-02-06
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-02-06 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-02-06
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-02-06 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2026-01-20
Form 8-K - Current report
Key Events
2026-01-20 · Key Events
Form 8-K - Current report
2026-01-12
Form 8-K - Current report
Key Events
2026-01-12 · Key Events
Form 8-K - Current report
2025-12-19
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Key Events
2025-12-19 · Key Events
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
2025-12-18
Form 8-K - Current report
Key Events
2025-12-18 · Key Events
Form 8-K - Current report
2025-12-09
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Key Events
2025-12-09 · Key Events
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
2025-12-09
Form 8-K - Current report
Key Events
2025-12-09 · Key Events
Form 8-K - Current report
2025-12-03
Form DEFM14A - Definitive proxy statement relating to merger or acquisition
2025-12-03 ·
Form DEFM14A - Definitive proxy statement relating to merger or acquisition
2025-12-02
Form PRER14A - Preliminary Proxy Soliciting materials
2025-12-02 ·
Form PRER14A - Preliminary Proxy Soliciting materials
